Tiotropium
Indications
Tiotropium is used for:
Asthma, COPD
Adult Dose
Inhalation
Asthma; Chronic obstructive pulmonary disease
Adult: As Inhaler: 2 puffs (18mcg) once daily.
As inhalation cap: 1 cap (18 mcg) daily via inhaler device, at the same time each day.
Child Dose
Inhalation
Asthma
Child> 12 years: As Inhaler: 2 puffs (18mcg) once daily.
Child> 18 years: As inhalation cap: 1 cap (18 mcg) daily via inhaler device, at the same time each day.
Renal Dose
Renal impairment:
CrCl (ml/min) Dosage Recommendation
<50 Use w/ caution.
Administration
Contra Indications
Hypersensitivity to atropine and its derivatives (e.g. ipratropium).
Precautions
Patient w/ narrow-angle glaucoma, prostatic hyperplasia/bladder neck obstruction, cystic fibrosis. History of MI (<6 mth), or unstable or life threatening cardiac arrhythmia w/in the past yr. Not intended for use as initial treatment for acute bronchospasm and as monotherapy for asthma. Moderate to severe renal impairment (CrCl ≤50 mL/min). Pregnancy and lactation. Patient Counselling This drug may cause dizziness and blurred vision, if affected, do not drive or operate machinery. Monitoring Parameters Monitor pulmonary function.
Pregnancy-Lactation
Interactions
Other anticholinergic agents.
Adverse Effects
Side effects of Tiotropium :
>10%
Upper respiratory tract infection (41%),Dry mouth (16%),Sinusitis (11%)
1-10%
Abdominal pain,Allergic reaction,Angina pectoris (including aggravated angina pectoris),Cataract,Chest pain (nonspecific),Constipation,Depression,Dyspepsia,Dysphonia,Edema,Epistaxis,Gastroesophageal reflux,Herpes zoster,Hypercholesterolemia,Hyperglycemia,Infection,Laryngitis,Leg pain,Moniliasis,Myalgia,Paresthesia,Pharyngitis,Rash,Rhinitis,Skeletal pain,Stomatitis (including ulcerative stomatitis),Urinary tract infection,Vomiting
<1%
Angioedema,Fibrillation,Supraventricular tachycardia,Urinary retention
Mechanism of Action
Tiotropium bromide, a long-acting quaternary ammonium antimuscarinic, is structurally related to ipratropium. It is a nonselective competitive antagonist of muscarinic (M1-M5) receptors and causes bronchodilation by inhibiting the actions of acetylcholine and other cholinergic stimuli at M3 receptors in the smooth muscle of the respiratory tract.